Cosmo Pharmaceuticals N.V Tangible Net Worth Ratio
Cosmo Pharmaceuticals N.V tangible net worth ratio. Cosmo Pharmaceuticals N.V (C43) has a Tangible Net Worth Ratio of 33.4% as of December 2025. This metric is calculated by deducting intangible assets (€325.88 Million) from net assets (€489.18 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check strategic asset allocation of Cosmo Pharmaceuticals N.V to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Cosmo Pharmaceuticals N.V (2016–2025)
Tangible net worth ratio of Cosmo Pharmaceuticals N.V from 2016 to 2025. This chart shows how Cosmo Pharmaceuticals N.V's Tangible Net Worth Ratio has changed across 10 annual periods from 2016 to 2025. As of December 2025, the ratio stands at 33.4%, reflecting net assets of €489.18 Million with intangible assets of €325.88 Million EUR. See C43 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Cosmo Pharmaceuticals N.V Tangible Net Worth Ratio by Year (2016–2025)
Cosmo Pharmaceuticals N.V tangible net worth ratio by year from 2016 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Cosmo Pharmaceuticals N.V from 2016 to 2025, covering 10 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Cosmo Pharmaceuticals N.V (C43) market capitalisation.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 33.4% | €489.18 Million | €325.88 Million | €612.64 Million | ▼ -0.9 pp |
| 2024 | 34.3% | €505.09 Million | €331.93 Million | €646.77 Million | ▲ +18.1 pp |
| 2023 | 16.2% | €403.62 Million | €338.36 Million | €526.04 Million | ▼ -4.8 pp |
| 2022 | 21.0% | €463.79 Million | €366.39 Million | €759.59 Million | ▼ -6.3 pp |
| 2021 | 27.3% | €512.68 Million | €372.73 Million | €805.56 Million | ▼ -66.0 pp |
| 2020 | 93.3% | €400.12 Million | €26.64 Million | €596.16 Million | ▲ +5.8 pp |
| 2019 | 87.5% | €393.73 Million | €49.22 Million | €585.16 Million | ▼ -4.5 pp |
| 2018 | 92.0% | €444.85 Million | €35.52 Million | €625.69 Million | ▼ -1.9 pp |
| 2017 | 93.9% | €470.12 Million | €28.52 Million | €497.97 Million | ▼ -1.4 pp |
| 2016 | 95.3% | €415.56 Million | €19.55 Million | €443.47 Million | — |